1. Home
  2. CWD vs NOTV Comparison

CWD vs NOTV Comparison

Compare CWD & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CaliberCos Inc.

CWD

CaliberCos Inc.

HOLD

Current Price

$0.97

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.27

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWD
NOTV
Founded
2009
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.8M
IPO Year
2022
1997

Fundamental Metrics

Financial Performance
Metric
CWD
NOTV
Price
$0.97
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
249.2K
657.4K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
49.64
EPS
N/A
N/A
Revenue
$20,097,000.00
$547,656,000.00
Revenue This Year
N/A
$5.28
Revenue Next Year
$19.17
$5.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
511.19
52 Week Low
$0.87
$0.22
52 Week High
$46.21
$3.31

Technical Indicators

Market Signals
Indicator
CWD
NOTV
Relative Strength Index (RSI) 43.32 45.71
Support Level $0.91 $0.24
Resistance Level $1.13 $0.34
Average True Range (ATR) 0.08 0.03
MACD 0.00 -0.00
Stochastic Oscillator 32.22 32.96

Price Performance

Historical Comparison
CWD
NOTV

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: